While this was the first case of evaluating the effects of the mutant version of the natural tumor suppressor, earlier studies using a mutant p53 – at that time thought to be the natural existing form prior to the knowledge that p53 is actually a tumor suppressor – also showed growth advantage due to its overexpression (33). The gene discussed is TP53; the disease is neoplasm.